RenovoRx (NASDAQ:RNXT) Given New $11.50 Price Target at Ascendiant Capital Markets
RenovoRx (NASDAQ:RNXT – Get Free Report) had its target price boosted by analysts at Ascendiant Capital Markets from $11.00 to $11.50 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. Separately, HC Wainwright reiterated a “buy” rating and set a $3.00 target price on […]
